{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-137744","form_type":"8-K","ticker":"KRYS","cik":"0001711279","company_name":"Krystal Biotech, Inc.","filed_at":"2023-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.162383+00:00","generated_at":"2026-06-15T13:44:48.339164+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Krystal Biotech enters $150M ATM equity offering with Cowen","bullets":["Sales agreement with Cowen for at-the-market offering of up to $150M common stock.","Cowen receives 3.0% commission on gross proceeds from each sale; no obligation to sell.","Shares offered under existing shelf registration; proceeds for general corporate purposes.","Either party may suspend or terminate the offering with notice."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-137744","json":"https://secwatch.observer/filing/0001193125-23-137744.json","markdown":"https://secwatch.observer/filing/0001193125-23-137744.md","text":"https://secwatch.observer/filing/0001193125-23-137744.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1711279/000119312523137744/0001193125-23-137744-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1711279/000119312523137744/d431837d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T13:44:48.339164+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1671278c15c728dce5668336c2bd44d7338a223f","claim":"Krystal Biotech, Inc. entered into Sales Agreement with Cowen and Company, LLC valued at up to $150.0 million (effective 2023-05-08).","evidence_excerpt":"On May 8, 2023, Krystal Biotech, Inc. (the “Company”) entered into a sales agreement (the “Sales Agreement”) with Cowen and Company, LLC (“Cowen”) to issue and sell shares of the Company’s common stock, par value $0.00001 per share, having an aggregate offering price of up to $150.0 million (the “Placement Shares”) from time to time during the term of the Sales Agreement, through an “at-the-market” equity offering program under which Cowen will act as the Company’s agent and/or principal.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1711279/000119312523137744/0001193125-23-137744-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"atm program"},{"label":"Counterparty","value":"Cowen and Company, LLC"},{"label":"Value","value":"up to $150.0 million"},{"label":"Effective","value":"2023-05-08"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}